Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective

Open access
Malik, Yashpal Singh, Kumar, Naveen, Sircar, Shubhankar, Kaushik, Rahul, Bhat, Sudipta, Dhama, Kuldeep, Gupta, Parakriti, Goyal, Kapil, Singh, Mini P, Ghoshal, Ujjala, El Zowalaty, Mohamed E., O. R, VinodhKumar, Yatoo, Mohd Iqbal, Tiwari, Ruchi, Pathak, Mamta, Patel, Shailesh Kumar, Sah, Ranjit, Rodriguez-Morales, Alfonso J, Ganesh, Balasubramanian, Kumar, Prashant, Singh, Raj Kumar · 2020 · Pathogens

Abstract

The technology-driven world of the 21st century is currently confronted with a major threat to humankind, represented by the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2). As of now, COVID-19 has affected more than 6 million confirmed cases and took 0.39 million human lives. SARS-CoV-2 spreads much faster than its two ancestors, SARS-CoV and Middle East respiratory syndrome-CoV (MERS-CoV), but has low fatality rates. Our analyses speculate that the efficient replication and transmission of SARS-CoV-2 might be due to the high-density basic amino acid residues, preferably positioned in close proximity at both the furin-like cleavage sites (S1/S2 and S2’) within the spike protein. Given the high genomic similarities of SARS-CoV-2 to bat SARS-like CoVs, it is likely that bats serve as a reservoir host for its progenitor. Women and children are less susceptible to SARS-CoV-2 infection, while the elderly and people with comorbidities are more prone to serious clinical outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. The cohesive approach amongst researchers across the globe has delivered high-end viral diagnostics. However, home-based point-of-care diagnostics are still under development, which may prove transformative in current COVID-19 pandemic containment. Similarly, vaccines and therapeutics against COVID-19 are currently in the pipeline for clinical trials. In this review, we discuss the noteworthy advancements, focusing on the etiological viral agent, comparative genomic analysis, population susceptibility, disease epidemiology and diagnosis, animal reservoirs, laboratory animal models, disease transmission, therapeutics, vaccine challenges, and disease mitigation measures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pathogens9070519

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 164

Metadata

Authors
Malik, Y. S., Kumar, N., Sircar, S., Kaushik, R., Bhat, S., Dhama, K., Gupta, P., Goyal, K., Singh, M. P., Ghoshal, U., El Zowalaty, M. E., O. R, V., Yatoo, M. I., Tiwari, R., Pathak, M., Patel, S. K., Sah, R., Rodriguez-Morales, A. J., Ganesh, B., Kumar, P., & Singh, R. K.
Venue
Pathogens
Publisher
MDPI AG
Published
2020-06-28
Volume
9
Issue
7
Pages
519
ISSN
2076-0817 (ISSN-L)
OpenAlex
W3037030172
Cited by
164
References
16
FWCI
4.07
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. https://app.cochat.ai/papers/10.3390/pathogens9070519
The paper
Malik, Y. S., Kumar, N., Sircar, S., Kaushik, R., Bhat, S., Dhama, K., Gupta, P., Goyal, K., Singh, M. P., Ghoshal, U., El Zowalaty, M. E., O. R, V., Yatoo, M. I., Tiwari, R., Pathak, M., Patel, S. K., Sah, R., Rodriguez-Morales, A. J., Ganesh, B., . . . Singh, R. K. (2020). Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens. https://doi.org/10.3390/pathogens9070519

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.